A Prospective Observational Study of Maintenance Plasma Exchange (PLEX) for Neuromyelitis Optica Spectrum Disorders (MultiPLEX Study)
Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system that is
associated with autoantibodies to aquaporin-4. Treatment options for prevention of clinical
relapses of NMO include immunosuppressive medications. Plasma exchange (PLEX) is commonly
used as a rescue therapy for NMO relapses but ongoing, regular PLEX procedures (maintenance
PLEX) is sometimes used to prevent relapses. This observational registry will record
feasibility, tolerability, safety, and preliminary efficacy data regarding maintenance PLEX
for participants with NMO, NMO spectrum disorders, and recurrent idiopathic longitudinally
extensive transverse myelitis.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Number of participants who complete planned maintenance PLEX regimen
One year
No
Dean M Wingerchuk, MD
Principal Investigator
Mayo Clinic
United States: Institutional Review Board
10-007339
NCT01500681
June 2012
Name | Location |
---|---|
Mayo Clinic | Rochester, Minnesota 55905 |
Mayo Clinic | Scottsdale, Arizona |